PMC:7318948 / 335-532
Annnotations
LitCovid-PMC-OGER-BB
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T8 | 6-11 | UBERON:0000062 | denotes | organ |
| T9 | 53-71 | CHEBI:35705;CHEBI:35705 | denotes | immunosuppressants |
| T10 | 108-116 | SP_7 | denotes | COVID-19 |
| T11 | 188-196 | SP_7 | denotes | COVID-19 |
| T90485 | 6-11 | UBERON:0000062 | denotes | organ |
| T79164 | 53-71 | CHEBI:35705;CHEBI:35705 | denotes | immunosuppressants |
| T39889 | 108-116 | SP_7 | denotes | COVID-19 |
| T93635 | 188-196 | SP_7 | denotes | COVID-19 |
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T2 | 0-11 | Body_part | denotes | Solid organ | http://purl.org/sig/ont/fma/fma55670 |
LitCovid-PD-UBERON
| Id | Subject | Object | Predicate | Lexical cue | uberon_id |
|---|---|---|---|---|---|
| T2 | 6-11 | Body_part | denotes | organ | http://purl.obolibrary.org/obo/UBERON_0000062 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T5 | 108-116 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T6 | 188-196 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T4 | 6-11 | http://purl.obolibrary.org/obo/UBERON_0003103 | denotes | organ |
| T5 | 84-85 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 25 | 117-125 | Species | denotes | patients | Tax:9606 |
| 33 | 108-116 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 34 | 188-196 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T4 | 0-197 | Sentence | denotes | Solid organ transplant recipients who are on chronic immunosuppressants fall within a special population of COVID-19 patients since they are more susceptible to complications secondary to COVID-19. |